{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"352"}],"units":"Participants"}],"groups":[{"description":"all patients who received rhPSMA-7.3 (18F) injection followed by a PET scan. This population included M0 and M1 patients independent of performance of RP and PLND and was used for M1 related efficacy and Kappa statistics.","id":"OG000","title":"Extended Efficacy Population (EEP)"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Conventional images within 60 days or at least 24 hours prior to rhPSMA-7.3 (18F) PET, followed by treatment within 60 days post IMP administration","title":"The Percentage of Patients in Whom Planned RP Was Converted to EBRT. (Objective 6b)","type":"SECONDARY","unitOfMeasure":"percentage"}